Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus

BACKGROUND: Little is known about the influence of ongoing barriers to care in the persistence of hepatitis C virus (HCV) viremia after treatment with direct-acting antivirals (DAAs) among people living with human immunodeficiency virus (PLWH). METHODS: We conducted a retrospective cohort analysis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cachay, Edward R, Mena, Alvaro, Morano, Luis, Benitez, Laura, Maida, Ivana, Ballard, Craig, Hill, Lucas, Torriani, Francesca, Castro, Angeles, Dore, Elena, Castro, Sheila, de Mendoza Fernández, Carmen, Soriano, Vicente, Mathews, Wm C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440685/
https://www.ncbi.nlm.nih.gov/pubmed/30949524
http://dx.doi.org/10.1093/ofid/ofz070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440685/
https://www.ncbi.nlm.nih.gov/pubmed/30949524
http://dx.doi.org/10.1093/ofid/ofz070

Ejemplares similares